CVRx, Inc. (CVRX) Guidance & Earnings Results

On 2026-08-06 CVRx, Inc. lowered guidance: "Full-year revenue $58-60M; Q3 revenue…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CVRXCVRx, Inc.Follow CVRX — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 37.8M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 3 Nov, in 10 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Aug 26	Lowered	Full-year revenue $58-60M; Q3 revenue $13.5-14.5M · full year
11 May 26	Reaffirmed	FY2026 revenue $63M-$67M, gross margin 85%-87% (raised from 84%-86%), operating expenses $103M-$107M · full year
12 Jan 26	Raised	FY2026 revenue guidance $63-67M (+11-18% YoY) vs FY2025 $56.5-56.7M (+10-11% YoY) · full year
5 Nov 25	Mixed	FY2025 revenue guidance narrowed to $55.6-56.6M (midpoint $56.1M vs prior $56.0M), gross margin raised to 85-86% (from 83-84%), operating expenses raised to $98-99M (from $96-98M). Q4 2025 revenue gui · full year
4 Aug 25	Mixed	FY2025 revenue narrowed to $55.0-57.0M from $55.0-58.0M; gross margin 83-84%; opex $96-98M vs prior $95-98M; Q3 2025 revenue $13.7-14.7M · full year

CVRx, Inc. — questions

What guidance did CVRx, Inc. give?: On 2026-08-06: "Full-year revenue $58-60M; Q3 revenue $13.5-14.5M"
When does CVRx, Inc. report earnings?: CVRx, Inc.'s next earnings report is expected on 2026-11-03.

Every figure on this page comes from CVRx, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.